MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/cen.70219

Медицинская библиотека · Clinical endocrinology · 2026

Endoscopic Ultrasound-Guided Ethanol Ablation for Benign Insulinoma: A Single-Centre Experience and Literature Review.

Wu Yuchao, Shi Haitao, Wu Xiaokang, Kong Ying, Li Xueqian, Yan Lijing, Wu Juanjuan, Ding Shimei, Zhang Jing, Zhang Ruo, Zhang Chunhong, Xu Jing, Jing Aiyu, Xie Xuan, Ma Shiyang, Jiao Yang

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

Insulinoma is a predominantly benign pancreatic neuroendocrine tumour that is traditionally managed surgically. However, surgical invasiveness and anaesthesia-related risks limit its applicability in selected patients. Endoscopic ultrasound (EUS)-guided ethanol ablation has emerged as a minimally invasive alternative. This study aimed to evaluate the efficacy, safety, and feasibility of EUS-guided ethanol ablation for benign insulinoma.

METHODS

We retrospectively analysed 17 patients with insulinoma who underwent EUS-guided ethanol ablation, predominantly as a primary treatment. All procedures were performed by experienced gastroenterologists using 95% absolute ethanol.

RESULTS

The study cohort had a mean age of 58.47 ± 12.29 years and a mean disease duration of 34.43 months (range, 0.36-84.0). Clinical success was achieved in 16 patients (94.1%). One patient with an initial suboptimal response successfully underwent a repeat ablation after 8 months. Over a median follow-up period of 46.1 months (range, 6.6-97.8), one patient was lost to follow-up. Disease recurrence was observed in four patients, resulting in a recurrence rate of 25% (4/16) among those with available follow-up data. Three recurrent cases underwent repeat ablation, all achieving symptomatic resolution. A total of 22 ablation procedures were performed. Adverse events were documented in 36.4% (8/22) of procedures, with the majority being mild (31.8%, 7/22) and one severe adverse event (4.5%, 1/22).

CONCLUSIONS

EUS-guided ethanol ablation is an effective and well-tolerated treatment for benign insulinoma. It represents a viable minimally invasive alternative to surgery and remains effective for managing recurrence or initial treatment failure without compromising subsequent surgical options.

Для цитирования: Wu Yuchao, Shi Haitao, Wu Xiaokang, Kong Ying, Li Xueqian, Yan Lijing, Wu Juanjuan, Ding Shimei, Zhang Jing, Zhang Ruo, Zhang Chunhong, Xu Jing, Jing Aiyu, Xie Xuan, Ma Shiyang, Jiao Yang. Endoscopic Ultrasound-Guided Ethanol Ablation for Benign Insulinoma: A Single-Centre Experience and Literature Review.. Clinical endocrinology. 2026. DOI: 10.1111/cen.70219.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.